Media Centre

Discover how BioVendor Group’s fully automated CLIA solution supports accurate, fast, and intuitive laboratory testing across AGEL laboratories.

Entering a new era to accelerate innovation and strengthen customer support.

Chronic kidney disease is often detected too late. Uromodulin offers a new perspective for earlier and more sensitive diagnostics.

At our booth #4255, we showcased the Group’s portfolio, created through the synergy of research, development, and technological expertise across BioVendor Group.

Neuroendocrine tumor diagnostics made more precise with new IVDR-certified Chromogranin A CLIA kit.

IVDR-certified MBA Liver Profile kit offers reliable support for the early detection of autoimmune liver diseases.

Brussels hosted the 26^th edition of the prestigious international congress focused on clinical chemistry and laboratory medicine. We were there – both as an exhibitor and as a contributor to the scientific programme.

HSV infections are common but often hidden. Diagnostics reveal even asymptomatic cases and help protect vulnerable patients.

Get to know epicGEN – next-generation NGS panels for precise genome analysis. The new epicGEN Solid Cancer & MSI Kit is designed for targeted analysis of 42 genes relevant for the diagnostics of solid tumors and the detection of genetic changes (InDel, SNP, CNV and MSI).

BioVendor Group changes ownership to partner with a healthcare specialist, strengthening its development and expansion capacities in the global diagnostics market.

From sequencing to artificial intelligence: Trends shaping the future of laboratory diagnostics

While this motto sets the tone for the upcoming MEDICA 2025, it perfectly encapsulated the spirit of this year’s event, which took place in the second week of November in Düsseldorf.

BioVendor Group introduces the innovative test for the detection of microsatellite instability leverages state-of-the-art NGS technology.

Reveal lactose, fructose, and histamine intolerance with NGS – all in one test.

Cutting-edge immunological biomarker and its role in managing infections and immune responses

The 57th ESHG 2024 is behind us, gathering over 4,500 experts in human genetics.

BioVendor MDx introduces the first commercial NGS assay for the detection of the BCR::ABL1 fusion gene.